(Q44970315)

7 December 2017

title

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia (English)

1 reference

7 December 2017

1 reference

1 reference

Staphylococcus aureus

1 reference

1

Alain Combes

1 reference

7 December 2017

Charles-Edouard Luyt

2

1 reference

7 December 2017

Jean-Yves Fagon

3

1 reference

7 December 2017

Michel Wollf

4

1 reference

7 December 2017

Jean-Louis Trouillet

5

1 reference

7 December 2017

Claude Gibert

6

1 reference

7 December 2017

Jean Chastre

7

1 reference

7 December 2017

PNEUMA Trial Group

8

1 reference

7 December 2017

language of work or name

English

0 references

publication date

8 July 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

7 December 2017

published in

1 reference

7 December 2017

volume

170

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

786-792

1 reference

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Risk factors for mortality in Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

The impact of methicillin resistance on the outcome of poststernotomy mediastinitis due to Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

The effect of methicillin on skin lesions in guinea-pigs caused by "methicillin-sensitive" and "methicillin-resistant" Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Relationship Between Antibiotic Resistance, the Production of "Virulence Factors", and Virulence for Experimental Animals in Staphylococcus Aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Comparison of In Vitro Adherence of Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus to Human Nasal Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Methicillin-Resistant Strains of Staphylococcus aureus: Relation between Expression of Resistance and Phagocytosis by Polymorphonuclear Leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Penetration of vancomycin into human lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Intrapulmonary pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-346OC

10.1164/RCCM.200403-346OC

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference